Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |